Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANCX
6351
DELISTED
Access National Corp
ANCX
| $291K | ﹤0.01% |
+10,458
| New | +$300K |
|
|
STKL
6352
DELISTED
SunOpta
STKL
| $290K | ﹤0.01% |
37,451
-17,122
| -31% | -$143K |
|
6353
Idacorp
IDA
$8.25B
| $289K | ﹤0.01% |
+3,167
| New | +$296K |
|
6354
Innoviva
INVA
$1.53B
| $289K | ﹤0.01% |
20,395
-140,061
| -87% | -$1.87M |
|
|
VGR
6355
PUT
DELISTED
Vector Group Ltd.
VGR
| $289K | ﹤0.01% |
20,053
-21,771
| -52% | -$303K |
|
|
OSB
6356
DELISTED
Norbord Inc.
OSB
| $289K | ﹤0.01% |
+8,536
| New | +$305K |
|
|
WPG
6357
CALL
DELISTED
Washington Prime Group Inc.
WPG
| $289K | ﹤0.01% |
4,511
+2,311
| +105% | +$157K |
|
6358
CALL
Artisan Partners
APAM
$2.99B
| $288K | ﹤0.01% |
7,300
-500
| -6% | -$18.5K |
|
6359
Descartes Systems
DSGX
$6.62B
| $288K | ﹤0.01% |
+10,145
| New | +$292K |
|
6360
CALL
Globus Medical
GMED
$11.5B
| $288K | ﹤0.01% |
7,000
-1,300
| -16% | -$45.5K |
|
6361
PUT
Hovnanian Enterprises
HOV
$785M
| $288K | ﹤0.01% |
3,440
-256
| -7% | -$15.8K |
|
6362
PUT
Malibu Boats
MBUU
$576M
| $288K | ﹤0.01% |
+9,700
| New | +$296K |
|
6363
PUT
Star Bulk Carriers
SBLK
$3.24B
| $288K | ﹤0.01% |
25,600
+11,400
| +80% | +$118K |
|
6364
W.P. Carey
WPC
$16.3B
| $288K | ﹤0.01% |
+4,267
| New | +$292K |
|
|
NS
6365
CALL
DELISTED
NuStar Energy L.P.
NS
| $288K | ﹤0.01% |
9,600
+1,600
| +20% | +$51.9K |
|
|
CBM
6366
CALL
DELISTED
Cambrex Corporation
CBM
| $288K | ﹤0.01% |
6,000
-6,600
| -52% | -$327K |
|
6367
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.09M
| $287K | ﹤0.01% |
1,628
+94
| +6% | +$16.7K |
|
|
BBBY
6368
Bed Bath & Beyond
BBBY
$415M
| $287K | ﹤0.01% |
5,982
-14,945
| -71% | -$540K |
|
6369
CALL
Choice Hotels
CHH
$4.7B
| $287K | ﹤0.01% |
+3,700
| New | +$270K |
|
6370
PUT
Celldex Therapeutics
CLDX
$3.29B
| $287K | ﹤0.01% |
6,740
-13
| -0.2% | -$557 |
|
6371
iShares Latin America 40 ETF
ILF
$3.71B
| $287K | ﹤0.01% |
+8,387
| New | +$285K |
|
6372
PUT
Global X Social Media ETF
SOCL
$92.9M
| $287K | ﹤0.01% |
+8,700
| New | +$286K |
|
|
RTEC
6373
PUT
DELISTED
Rudolph Technologies Inc
RTEC
| $287K | ﹤0.01% |
+12,000
| New | +$308K |
|
6374
Select Water Solutions
WTTR
$2.69B
| $286K | ﹤0.01% |
+15,690
| New | +$252K |
|
|
AVTA
6375
DELISTED
Avantax, Inc. Common Stock
AVTA
| $286K | ﹤0.01% |
12,953
+4,595
| +55% | +$102K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.